NanoFuse Research
Featured Study
Nanofuse Unique Combination of Synthetic Bioactive Glass plus DBM in Cervical Spine Fusion
Kingsley R. Chin^, Erik Spayde, William M. Costigan, Vito Lore, Chukwunonso Ilogu , Jason A Seale
Our study demonstrated 100% fusion rate. VAS neck and NDI outcomes improved by 89% and 68% respectively with the use of combination biologic. Signs of fusion were seen as early as 6 weeks with anterior bridging bone
NanoFuse Studies
Osteoconductivity and osteoinductivity of NanoFUSE(®) DBM
James F. Kirk*, Gregg Ritter, Chad Waters, Sonoko Narisawa, José Luis Millán, and James D. Talton
NanoFuse DBM showing superior bone growth results over DBM alone
James F. Kirk, Gregg Ritter, Michael J. Larson, Robert C. Waters, Isaac finger, John Waters, John H. Abernethy, Dhyana Sankar, James D. Talton, Ronald R. Cobb
Fusion for NanoFuse alone was 61% while no fusion observed in the sham or NovaBone Putty groups at 24 weeks
Bioactive glass in tissue engineering
Mohamed N. Rahamana,*, Delbert E. Daya, B. Sonny Balb, Qiang Fuc, Steven B. Junga,d, Lynda F. Bonewalde, Antoni P. Tomsia
Bioactive glass has also been shown to enhance neocartilage formation during in vitro culture of chondrocyte-seeded hydrogels, and to serve as a subchondral substrate for tissue-engineered osteochondral constructs
